| Dr Sajjad Hussain, MEDICAL DOCTOR | |
|
1364 Route 72 W, Suite 2, Manahawkin, NJ 08050-2485 | |
| (609) 597-3616 | |
| (609) 597-4557 |
| Full Name | Dr Sajjad Hussain |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 36 Years |
| Location | 1364 Route 72 W, Manahawkin, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780672188 | NPI | - | NPPES |
| 0069779 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 25MA066885500 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Ocean Medical Center | Manahawkin, NJ | Hospital |
| Jersey Shore University Medical Center | Neptune, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Optum Medical Care Of New Jersey Pc | 3072650290 | 231 |
News Archive
Lockheed Martin will take steps to accelerate the advancement of digital health records and secure health information exchanges with two new agreements to support the Nationwide Health Information Network. The contracts, which were awarded by the Department of Health and Human Services' Office of the National Coordinator for Health Information Technology (ONC), total $9 million over two years.
According to a new study nearly 15 percent of people who have a stroke are not eligible for clot-busting treatment because the stroke happened while they slept. These clot breaking drugs can prevent permanent disability after a stroke - but the treatment must be given within a four-and-a-half-hour window after the stroke symptoms begin say experts. Since people who have a stroke while asleep can't know when it occurred, they can't get the treatment if they slept for more than four and a half hours, explained study author Dr. Jason Mackey at the University of Cincinnati. "They can't get the drug," he said. "That's a big issue."
Local scientists, health advocates and leaders from the California Institute for Regenerative Medicine will gather in San Diego June 23 for a special public meeting to spotlight a new University of California, San Diego grant to pursue novel, fast-tracked stem cell-based therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.
FzioMed, Inc. today announced it has agreed with the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) to postpone the Dispute Resolution Panel for its Oxiplex PMA; the meeting was previously scheduled for June 10.z
Diagnosing chronic kidney disease, which is often undetected until it causes irreversible damage, may soon become automated with a new algorithm that interprets data from electronic medical records.
› Verified 8 days ago
| Entity Name | Stafford Medical, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558382457 PECOS PAC ID: 2466434451 Enrollment ID: O20040603000555 |
News Archive
Lockheed Martin will take steps to accelerate the advancement of digital health records and secure health information exchanges with two new agreements to support the Nationwide Health Information Network. The contracts, which were awarded by the Department of Health and Human Services' Office of the National Coordinator for Health Information Technology (ONC), total $9 million over two years.
According to a new study nearly 15 percent of people who have a stroke are not eligible for clot-busting treatment because the stroke happened while they slept. These clot breaking drugs can prevent permanent disability after a stroke - but the treatment must be given within a four-and-a-half-hour window after the stroke symptoms begin say experts. Since people who have a stroke while asleep can't know when it occurred, they can't get the treatment if they slept for more than four and a half hours, explained study author Dr. Jason Mackey at the University of Cincinnati. "They can't get the drug," he said. "That's a big issue."
Local scientists, health advocates and leaders from the California Institute for Regenerative Medicine will gather in San Diego June 23 for a special public meeting to spotlight a new University of California, San Diego grant to pursue novel, fast-tracked stem cell-based therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.
FzioMed, Inc. today announced it has agreed with the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) to postpone the Dispute Resolution Panel for its Oxiplex PMA; the meeting was previously scheduled for June 10.z
Diagnosing chronic kidney disease, which is often undetected until it causes irreversible damage, may soon become automated with a new algorithm that interprets data from electronic medical records.
› Verified 8 days ago
| Entity Name | Optum Medical Care Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578665048 PECOS PAC ID: 3072650290 Enrollment ID: O20091021000129 |
News Archive
Lockheed Martin will take steps to accelerate the advancement of digital health records and secure health information exchanges with two new agreements to support the Nationwide Health Information Network. The contracts, which were awarded by the Department of Health and Human Services' Office of the National Coordinator for Health Information Technology (ONC), total $9 million over two years.
According to a new study nearly 15 percent of people who have a stroke are not eligible for clot-busting treatment because the stroke happened while they slept. These clot breaking drugs can prevent permanent disability after a stroke - but the treatment must be given within a four-and-a-half-hour window after the stroke symptoms begin say experts. Since people who have a stroke while asleep can't know when it occurred, they can't get the treatment if they slept for more than four and a half hours, explained study author Dr. Jason Mackey at the University of Cincinnati. "They can't get the drug," he said. "That's a big issue."
Local scientists, health advocates and leaders from the California Institute for Regenerative Medicine will gather in San Diego June 23 for a special public meeting to spotlight a new University of California, San Diego grant to pursue novel, fast-tracked stem cell-based therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.
FzioMed, Inc. today announced it has agreed with the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) to postpone the Dispute Resolution Panel for its Oxiplex PMA; the meeting was previously scheduled for June 10.z
Diagnosing chronic kidney disease, which is often undetected until it causes irreversible damage, may soon become automated with a new algorithm that interprets data from electronic medical records.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sajjad Hussain, MEDICAL DOCTOR 14103 Bainbridge Way, Freehold, NJ 07728-4877 Ph: () - | Dr Sajjad Hussain, MEDICAL DOCTOR 1364 Route 72 W, Suite 2, Manahawkin, NJ 08050-2485 Ph: (609) 597-3616 |
News Archive
Lockheed Martin will take steps to accelerate the advancement of digital health records and secure health information exchanges with two new agreements to support the Nationwide Health Information Network. The contracts, which were awarded by the Department of Health and Human Services' Office of the National Coordinator for Health Information Technology (ONC), total $9 million over two years.
According to a new study nearly 15 percent of people who have a stroke are not eligible for clot-busting treatment because the stroke happened while they slept. These clot breaking drugs can prevent permanent disability after a stroke - but the treatment must be given within a four-and-a-half-hour window after the stroke symptoms begin say experts. Since people who have a stroke while asleep can't know when it occurred, they can't get the treatment if they slept for more than four and a half hours, explained study author Dr. Jason Mackey at the University of Cincinnati. "They can't get the drug," he said. "That's a big issue."
Local scientists, health advocates and leaders from the California Institute for Regenerative Medicine will gather in San Diego June 23 for a special public meeting to spotlight a new University of California, San Diego grant to pursue novel, fast-tracked stem cell-based therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.
FzioMed, Inc. today announced it has agreed with the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) to postpone the Dispute Resolution Panel for its Oxiplex PMA; the meeting was previously scheduled for June 10.z
Diagnosing chronic kidney disease, which is often undetected until it causes irreversible damage, may soon become automated with a new algorithm that interprets data from electronic medical records.
› Verified 8 days ago
Meghavi J Patel, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1140 Route 72 W, Manahawkin, NJ 08050 Phone: 609-597-6011 | |
Vincent Abenante, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 588 E Bay Ave, Suite 1, Manahawkin, NJ 08050 Phone: 609-489-0220 Fax: 609-489-0228 | |
Dr. Michael J. Kirk Jr., D.O., PHARM.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1140 Route 72 W, Manahawkin, NJ 08050 Phone: 609-978-3331 | |
Frank C Labue, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1301 Route 72 W, Suite 300, Manahawkin, NJ 08050 Phone: 609-597-6513 Fax: 609-597-4593 | |
Dr. Kristophe Mikhail, Anthony Anderson, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1140 Route 72 W, Manahawkin, NJ 08050 Phone: 609-597-6011 | |
Helio J Malinverni, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1301 Route 72 W, Suite 300, Manahawkin, NJ 08050 Phone: 609-597-6513 Fax: 609-597-4593 | |
Dr. Harsh Virendra Bhavsar, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1140 Nj-72 West, Manahawkin, NJ 08050 Phone: 610-237-4000 |